Tarsus acquires IRX-101 intravitreal injection asset from iRenix Medical. The candidate showed 50% pain reduction versus povidone-iodine in Phase...

NovMetaPharma and FSHD Canada Foundation partner on Cyclo-Z, combining cyclo-his-pro and zinc to address progressive skeletal muscle loss in...

TaiMed Biologics obtains Taiwan approval for Trogarzo HIV treatment, advancing its international expansion strategy and pipeline development efforts.

Praxis and Remagine Labs partner on transdermal ulixacaltamide for essential tremor, expanding delivery options ahead of the January 2027...

Aligos receives $25M upfront and up to $420M in milestones for pevifoscorvir sodium in Greater China, with NMPA Breakthrough...

Takeda partners with Insilico Medicine in $600M AI drug discovery deal to develop candidates across GI, inflammatory, oncology, and...

Madrigal and Ribo advance first siRNA candidate for MASH treatment, entering IND-enabling studies to expand therapeutic options for the...

XTL Biopharmaceuticals acquires Psyga Bio's psilocybin pipeline for depression and PTSD, leveraging FDA acceleration policy and in-house GMP manufacturing.

Nxera Pharma receives $10M milestone from AbbVie in neurology GPCR collaboration, bringing cumulative payments to $40M since 2022 partnership...

Hanmi Pharmaceutical acquires Aptose Biosciences for C$2.41 per share, gaining tuspetinib for AML triplet therapy development.